Massachusetts Financial Services’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-163,104
| Closed | -$571K | – | 890 |
|
|
2024
Q3 | $571K | Sell |
163,104
-3,951
| -2% | -$13.8K | ﹤0.01% | 813 |
|
|
2024
Q2 | $548K | Buy |
167,055
+5,605
| +3% | +$18.4K | ﹤0.01% | 824 |
|
|
2024
Q1 | $1.19M | Buy |
+161,450
| New | +$1.19M | ﹤0.01% | 771 |
|
|
2023
Q3 | – | Sell |
-34,362
| Closed | -$164K | – | 849 |
|
|
2023
Q2 | $164K | Sell |
34,362
-809
| -2% | -$3.85K | ﹤0.01% | 815 |
|
|
2023
Q1 | $200K | Buy |
+35,171
| New | +$200K | ﹤0.01% | 831 |
|